Program to prevent peer aggression and dating violence in preteens receiving mental health services
Official title: Cross-Cutting Trauma-Informed Peer Aggression and Dating Violence Prevention for Preteens Receiving Intensive Mental Health Services
Run by Rhode Island Hospital · NCT06769282 · Data updated 2026-11-12
This study is testing a new program to see if it can help preteens in mental health treatment reduce bullying and dating violence by teaching them social skills and how to manage their emotions.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 11 Years to 13 Years |
| Sex | All |
| Enrollment | 88 (estimated) |
| Sponsor | Rhode Island Hospital Academic / other |
| Locations | 1 site (Providence, Rhode Island) |
| Status | Recruiting |
| Started | October 25, 2024 |
| Main results expected | June 30, 2026 |
| Study ends | March 30, 2027 |
| Registry record updated | January 10, 2025 |
| Trial ID | NCT06769282 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are preteens aged 11-13 years who are enrolled in a partial hospitalization program and require intensive mental health services.
✕Probably not a fit
Patients who are not enrolled in intensive mental health services or are outside the age range of 11-13 years may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the SPARE program, which aims to reduce peer aggression and prevent teen dating violence among preteens receiving intensive mental health services. The intervention includes social skills training, problem-solving, emotion regulation, and psycho-education on trauma, delivered through group therapy sessions. Participants will be compared to a control group receiving standard treatment to assess the effectiveness of SPARE in improving mental health outcomes and reducing aggressive behaviors over time.
Why it matters
Potential benefit: If successful, this program could significantly reduce aggression and dating violence among vulnerable preteens, leading to improved mental health and social outcomes.
How similar studies have gone: While similar interventions targeting aggression and dating violence have shown promise, the specific approach of SPARE is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * (1) aged 11-13 years * (2) enrolled in CP, * (3) ability to write and speak in English * (4) parent/guardian consent. Exclusion Criteria: * None
Where it's running
-
Rhode Island Hospital
Providence, Rhode Island, United States Recruiting
Study contacts
- Principal investigator: Elizabeth C Tampke, PhD — Rhode Island Hospital
- Study coordinator: Elizabeth C Tampke, Ph.D.
- Email: elizabeth_tampke@brown.edu
- Phone: (401) 793-8351
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PRAISE with Coaching to reduce aggression and bullying in 3rd–5th graders
This program tests whether training school staff, with ongoing coaching, to deliver the PRAISE curriculum reduces aggression and bullying among 3rd–5th graders.
-
What predicts improvement in irritability and aggression in children with ADHD on stimulant medication
This study sees if optimizing stimulant medication helps children with ADHD who have high irritability and aggression and whether brain and learning tests can predict who improves.
-
Online program to support families of LGBTQ youth
This study is testing an online program to help families of LGBTQ youth understand and support their children better, especially those from diverse backgrounds.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.